These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37596667)

  • 1. NEK8 regulates colorectal cancer progression via phosphorylating MYC.
    Cao B; Zhang K; Pan C; Dong Y; Lu F
    Cell Commun Signal; 2023 Aug; 21(1):209. PubMed ID: 37596667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in NEK8 link multiple organ dysplasia with altered Hippo signalling and increased c-MYC expression.
    Frank V; Habbig S; Bartram MP; Eisenberger T; Veenstra-Knol HE; Decker C; Boorsma RA; Göbel H; Nürnberg G; Griessmann A; Franke M; Borgal L; Kohli P; Völker LA; Dötsch J; Nürnberg P; Benzing T; Bolz HJ; Johnson C; Gerkes EH; Schermer B; Bergmann C
    Hum Mol Genet; 2013 Jun; 22(11):2177-85. PubMed ID: 23418306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
    Zhang Z; Gao Q; Wang S
    J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant position of C-myc in colorectal cancer: a promising therapeutic target.
    Tan L; Peng D; Cheng Y
    Clin Transl Oncol; 2022 Dec; 24(12):2295-2304. PubMed ID: 35972682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIP2A regulates MYC translation (via its 5'UTR) in colorectal cancer.
    Denk S; Schmidt S; Schurr Y; Schwarz G; Schote F; Diefenbacher M; Armendariz C; Dejure F; Eilers M; Wiegering A
    Int J Colorectal Dis; 2021 May; 36(5):911-918. PubMed ID: 33078202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STK16 promoted colorectal cancer progress in a c-MYC signaling-dependent manner.
    Peng L; Guangshi L; Wusman LB; Tao L
    Mol Med; 2024 Apr; 30(1):50. PubMed ID: 38622518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin blocks MYC protein synthesis in colorectal cancer via mTOR-4EBP-eIF4E and MNK1-eIF4G-eIF4E signaling.
    Shen P; Reineke LC; Knutsen E; Chen M; Pichler M; Ling H; Calin GA
    Mol Oncol; 2018 Nov; 12(11):1856-1870. PubMed ID: 30221473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance.
    Pranteda A; Piastra V; Serra M; Bernardini R; Lo Sardo F; Carpano S; Diodoro MG; Bartolazzi A; Milella M; Blandino G; Bossi G
    Biomed Pharmacother; 2023 Nov; 167():115480. PubMed ID: 37713993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
    Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
    Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.
    Allen-Petersen BL; Sears RC
    BioDrugs; 2019 Oct; 33(5):539-553. PubMed ID: 31392631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene variants of TCF7L2 are histopathologically important in colorectal cancers but do not have direct association with MYC expression.
    Ozkan Kucuk NE; Horozoglu C; Timirci Kahraman O; Arikan S; Farooqi AA; Turan S; Korkmaz G; Kelten Talu EC; Sabitaliyevich UY; Yaylim I
    Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):1-6. PubMed ID: 32133972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-181d and c-myc-mediated inhibition of CRY2 and FBXL3 reprograms metabolism in colorectal cancer.
    Guo X; Zhu Y; Hong X; Zhang M; Qiu X; Wang Z; Qi Z; Hong X
    Cell Death Dis; 2017 Jul; 8(7):e2958. PubMed ID: 28749470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Myc-driven stress addiction in colorectal cancer.
    Saeed H; Leibowitz BJ; Zhang L; Yu J
    Drug Resist Updat; 2023 Jul; 69():100963. PubMed ID: 37119690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis.
    Yue C; Chen J; Li Z; Li L; Chen J; Guo Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):240. PubMed ID: 33183350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc.
    Zhang J; Ren P; Xu D; Liu X; Liu Z; Zhang C; Li Y; Wang L; Du X; Xing B
    Cancer Lett; 2019 Jan; 440-441():106-115. PubMed ID: 30343112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.